rs931605

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_025074.7(FRAS1):​c.10683A>T​(p.Glu3561Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.179 in 1,605,288 control chromosomes in the GnomAD database, including 29,222 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1781 hom., cov: 32)
Exomes 𝑓: 0.18 ( 27441 hom. )

Consequence

FRAS1
NM_025074.7 missense

Scores

13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.401

Publications

16 publications found
Variant links:
Genes affected
FRAS1 (HGNC:19185): (Fraser extracellular matrix complex subunit 1) This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
FRAS1 Gene-Disease associations (from GenCC):
  • Fraser syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Fraser syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023269355).
BP6
Variant 4-78522683-A-T is Benign according to our data. Variant chr4-78522683-A-T is described in ClinVar as Benign. ClinVar VariationId is 261797.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRAS1NM_025074.7 linkc.10683A>T p.Glu3561Asp missense_variant Exon 69 of 74 ENST00000512123.4 NP_079350.5 Q86XX4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRAS1ENST00000512123.4 linkc.10683A>T p.Glu3561Asp missense_variant Exon 69 of 74 5 NM_025074.7 ENSP00000422834.2 Q86XX4-2

Frequencies

GnomAD3 genomes
AF:
0.140
AC:
21222
AN:
152052
Hom.:
1781
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0778
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.116
Gnomad ASJ
AF:
0.111
Gnomad EAS
AF:
0.00289
Gnomad SAS
AF:
0.0533
Gnomad FIN
AF:
0.147
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.134
GnomAD2 exomes
AF:
0.135
AC:
32513
AN:
240784
AF XY:
0.135
show subpopulations
Gnomad AFR exome
AF:
0.0737
Gnomad AMR exome
AF:
0.0753
Gnomad ASJ exome
AF:
0.116
Gnomad EAS exome
AF:
0.00171
Gnomad FIN exome
AF:
0.153
Gnomad NFE exome
AF:
0.201
Gnomad OTH exome
AF:
0.153
GnomAD4 exome
AF:
0.184
AC:
266904
AN:
1453118
Hom.:
27441
Cov.:
32
AF XY:
0.180
AC XY:
129775
AN XY:
722410
show subpopulations
African (AFR)
AF:
0.0740
AC:
2467
AN:
33356
American (AMR)
AF:
0.0814
AC:
3582
AN:
44020
Ashkenazi Jewish (ASJ)
AF:
0.113
AC:
2945
AN:
25948
East Asian (EAS)
AF:
0.00207
AC:
82
AN:
39570
South Asian (SAS)
AF:
0.0582
AC:
4960
AN:
85264
European-Finnish (FIN)
AF:
0.155
AC:
8203
AN:
52974
Middle Eastern (MID)
AF:
0.0947
AC:
545
AN:
5756
European-Non Finnish (NFE)
AF:
0.212
AC:
234465
AN:
1106184
Other (OTH)
AF:
0.161
AC:
9655
AN:
60046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
10032
20063
30095
40126
50158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7956
15912
23868
31824
39780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.139
AC:
21222
AN:
152170
Hom.:
1781
Cov.:
32
AF XY:
0.134
AC XY:
10006
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0776
AC:
3217
AN:
41482
American (AMR)
AF:
0.116
AC:
1776
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.111
AC:
385
AN:
3472
East Asian (EAS)
AF:
0.00289
AC:
15
AN:
5182
South Asian (SAS)
AF:
0.0531
AC:
256
AN:
4822
European-Finnish (FIN)
AF:
0.147
AC:
1562
AN:
10598
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.200
AC:
13584
AN:
68002
Other (OTH)
AF:
0.133
AC:
281
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
914
1829
2743
3658
4572
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.182
Hom.:
2131
Bravo
AF:
0.135
TwinsUK
AF:
0.229
AC:
848
ALSPAC
AF:
0.216
AC:
834
ESP6500AA
AF:
0.0776
AC:
290
ESP6500EA
AF:
0.197
AC:
1622
ExAC
AF:
0.136
AC:
16448
Asia WGS
AF:
0.0360
AC:
126
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fraser syndrome 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
0.053
DANN
Benign
0.050
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.15
T
MetaRNN
Benign
0.0023
T
MetaSVM
Benign
-0.97
T
PhyloP100
-0.40
PrimateAI
Benign
0.41
T
Sift4G
Benign
1.0
T
Vest4
0.029
ClinPred
0.0010
T
GERP RS
-1.1
gMVP
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs931605; hg19: chr4-79443837; COSMIC: COSV107294967; API